Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: Radiologic-pathologic correlation

American Journal of Neuroradiology

Volumn 35, Issue 8, 2014, Pages 1503-1508

  Kickingereder, Philipp ^a   Sahm, F ^a,b   Wiestler, B ^a,b   Roethke, M ^b   Heiland, S ^a   Schlemmer, H P ^b   Wick, W ^a,b   Von Deimling, A ^a,b   Bendszus, M ^a   Radbruch, A ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE; CONTRAST MEDIUM;

ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR SPACE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; LYMPHOMA; NONPARAMETRIC TEST; PROCEDURES;

BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GLIOBLASTOMA; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84907322517     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3915     Document Type: Article

References (33)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96 (Pubitemid 40349501)
2. Schlegel U. Primary CNS lymphoma. Ther Adv Neurol Disord 2009;2:93-104
3. Tofts PS. T1-weighted DCE imaging concepts: modelling, acquisition and analysis. MAGNETOM Flash 2010;30-39
4. Nguyen TB, Cron GO, Mercier JF, et al. Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas. AJNR Am J Neuroradiol 2012;33:1539-45
5. trans, determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 2006;27:409-17
6. Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853-58 (Pubitemid 44897736)
7. Sorensen AG, Batchelor TT, Zhang WT, et al. A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Res 2009;69:5296-300
8. Zhang W, Kreisl T, Solomon J, et al. Acute effects of bevacizumab on glioblastoma vascularity assessed with DCE-MRI and relation to patient survival. In: Proceedings of the 17th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii; April 18-24, 2009:282
9. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-67
10. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475-87 (Pubitemid 44897763)
11. Molnár PP, O'Neill BP, Scheithauer BW, et al. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol 1999;1:89-100
12. Schramm P, Xyda A, Klotz E, et al. Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010;20:2482-90
13. Warnke PC, Timmer J, Ostertag CB, et al. Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol 2005;57:136-39 (Pubitemid 40053326)
14. Toh CH, Wei KC, Chang CN, et al. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 2013;34:1145-49
15. Orton MR, d'Arcy JA, Walker-Samuel S, et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI. Phys Med Biol 2008;53:1225-39 (Pubitemid 351594423)
16. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109 (Pubitemid 47103521)
17. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7 (Pubitemid 13129630)
18. Bagher-Ebadian H, Jain R, Nejad-Davarani SP, et al. Model selection for DCE-T1 studies in glioblastoma. Magn Reson Med 2012;68:241-51
19. Bergamino M, Saitta L, Barletta L, et al. Measurement of blood-brain barrier permeability with T1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. ISRN Neurosci 2013;2013:6
20. Jain R, Bagher-Ebadian H, Narang J, et al. Optimal period of linearity using Patlak analysis in brain tumors. In: Proceedings of the 18th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Stockholm, Sweden; May 1-7, 2010:4090
21. Boxerman J, Schmainda K, Weisskoff R. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859-67 (Pubitemid 44897737)
22. Boxerman JL, Prah DE, Paulson ES, et al. The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MIONas a criterion standard. AJNR Am J Neuroradiol 2012;33:1081-87
23. Weisskoff RM, Boxerman JL, Sorensen AG, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the 2nd Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, San Francisco, California; August 6-12, 1994
24. Emblem K, Mouridsen K, Borra R, et al. Does DSC-derived CA extravasation correlate with DCE Ktrans? In: Proceedings of the 19th International Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada; May 6-13, 2011
25. Emblem KE, Bjornerud A, Mouridsen K, et al. T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI. Part II. Predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011;31:2054-64
26. Bjornerud A, Sorensen AG, Mouridsen K, et al. T1- and T2*-dominant extravasation correction in DSC-MRI: part I-theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011;31:2041-53
27. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713-25 (Pubitemid 36749220)
28. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusionweighted magnetic resonance imaging. Neurosci Lett 2003;338:119-22 (Pubitemid 36140152)
29. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507-14
30. Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217-25
31. Wong ET, Brem S. Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. J Natl Compr Canc Netw 2008;6:515-22 (Pubitemid 351760842)
32. Lister A, Abrey LE, Sandlund JT. Central nervous system lymphoma. Hematology Am Soc Hematol Educ Program 2002:283-96
33. Schlegel U, Hochberg F. Primary CNS lymphoma. In: Tonn JC, Westphal M, Rutka JT, et al, eds. Neuro-Oncology of CNS Tumors. Heidelberg, Germany: Springer-Verlag; 2006:292-302